Cleared Traditional

Sonata Transcervical Fibroid Ablation System 2.2

K222304 · Gynesonics, Inc. · Obstetrics & Gynecology
Nov 2022
Decision
99d
Days
Class 2
Risk

About This 510(k) Submission

K222304 is an FDA 510(k) clearance for the Sonata Transcervical Fibroid Ablation System 2.2, a Coagulator-cutter, Endoscopic, Unipolar (and Accessories) (Class II — Special Controls, product code KNF), submitted by Gynesonics, Inc. (Redwood City, US). The FDA issued a Cleared decision on November 8, 2022, 99 days after receiving the submission on August 1, 2022. This device falls under the Obstetrics & Gynecology review panel. Regulated under 21 CFR 884.4160.

Submission Details

510(k) Number K222304 FDA.gov
FDA Decision Cleared SESE
Date Received August 01, 2022
Decision Date November 08, 2022
Days to Decision 99 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF

Device Classification

Product Code KNF — Coagulator-cutter, Endoscopic, Unipolar (and Accessories)
Device Class Class II — Special Controls
CFR Regulation 21 CFR 884.4160

Similar Devices — KNF Coagulator-cutter, Endoscopic, Unipolar (and Accessories)

All 43
Sonata Transcervical Fibroid Ablation System 2.2
K250705 · Gynesonics, Inc. · Apr 2025
Sonata Transcervical Fibroid Ablation System 2.2
K240503 · Gynesonics, Inc. · Jul 2024
Sonata Transcervical Fibroid Ablation System 2.2 (SONATA2-220)
K233848 · Gynesonics, Inc. · Dec 2023
Sonata Transcervical Fibroid Ablation System 2.2
K211535 · Gynesonics, Inc. · Jun 2021
Sonata? Sonography-Guided Transcervical Fibroid Ablation System 2.1
K193516 · Gynesonics, Inc. · May 2020
Sonata Sonography-Guided Transcervical Fibroid Ablation System
K173703 · Gynesonics, Inc. · Aug 2018